7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine has been researched along with Liver Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Biagioni, S; Cardarelli, S; Cifone, MG; Cinque, B; Galli, F; Giardi, MF; Giorgi, M; Massimi, M; Panera, N; Ragusa, F | 1 |
1 other study(ies) available for 7-benzylamino-6-chloro-2-piperazino-4-pyrrolidinopteridine and Liver Neoplasms
Article | Year |
---|---|
Increase of Intracellular Cyclic AMP by PDE4 Inhibitors Affects HepG2 Cell Cycle Progression and Survival.
Topics: Carcinoma, Hepatocellular; Cell Cycle; Cell Cycle Proteins; Cell Proliferation; Cell Survival; Cyclic AMP; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Hep G2 Cells; Humans; Liver Neoplasms; Phosphodiesterase 4 Inhibitors; Piperazines; Pteridines; Rolipram | 2017 |